Pfizer Inc

Registered Principal Details

Business Or Interest:
Pharmaceutical manufacturing and healthcare.

Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries

CEO Name:
Ian Read
Director, Government Relations

Contact
JD
James DeMay
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
jskelton@politicomlaw.com
http://www.pfizer.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
James DeMay Exclusive Duties N/A Authorized On 12/28/2016 Withdrawn On N/A
Tony Langenohl Exclusive Duties N/A Authorized On 12/28/2016 Withdrawn On N/A
William J McCoshen Exclusive Duties N/A Authorized On 12/28/2016 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 306
Assembly Bill 306
Relating to: tracking the sale of pseudoephedrine products.

Bill Text and History

2017 Wisconsin Act 98

For
Notification Date
11/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 679
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

For
Notification Date
12/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 237
Senate Bill 237
Relating to: tracking the sale of pseudoephedrine products.

Bill Text and History

For
Notification Date
12/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

2017 Wisconsin Act 149

For
Notification Date
12/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Substitution of interchangeable biosimilars
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/6/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Legal Reform Bills
Development, drafting or introduction of a proposal relating to
Legal Reform Bills

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Fetal Tissue Research Ban
Development, drafting or introduction of a proposal relating to
Fetal Tissue Research Ban

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Medicaid Issues
Development, drafting or introduction of a proposal relating to
Medicaid Issues

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Behavioral Health Issues
Development, drafting or introduction of a proposal relating to
Behavioral Health Issues

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Substance Abuse Treatment
Development, drafting or introduction of a proposal relating to
Substance Abuse Treatment

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Pain Management Issues
Development, drafting or introduction of a proposal relating to
Pain Management Issues

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Vaccines and immunizations
Development, drafting or introduction of a proposal relating to
Vaccines and immunizations

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Regulation of the Pharmaceutical Industry
Development, drafting or introduction of a proposal relating to
Regulation of the Pharmaceutical Industry

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Prescribing Opioids
Development, drafting or introduction of a proposal relating to
Prescribing Opioids

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
Total Lobbying Expenditures 2017
January - June
$28,029.93
2017
July - December
$25,448.00
2018
January - June
$26,834.13
2018
July - December
$26,547.30
Total $106,859.36
Total Hours Communicating 2017
January - June
7.50
2017
July - December
9.00
2018
January - June
0.00
2018
July - December
7.50
Total 24.00
Total Hours Other 2017
January - June
42.00
2017
July - December
48.50
2018
January - June
72.50
2018
July - December
54.50
Total 217.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: tracking the sale of pseudoephedrine products.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
10%
2018
January - June
2018
July - December
Total 2%
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
15%
2018
January - June
2018
July - December
Total 4%
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
15%
2018
January - June
60%
2018
July - December
Total 22%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
1%
2017
July - December
2018
January - June
2018
July - December
Total < 1%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
1%
2017
July - December
2018
January - June
10%
2018
July - December
10%
Total 6%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
1%
2017
July - December
2018
January - June
2018
July - December
Total < 1%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
4%
2017
July - December
2018
January - June
2018
July - December
Total < 1%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
6%
2017
July - December
10%
2018
January - June
10%
2018
July - December
Total 7%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
7%
2017
July - December
2018
January - June
2018
July - December
Total 1%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
7%
2017
July - December
2018
January - June
10%
2018
July - December
20%
Total 10%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
12%
2017
July - December
10%
2018
January - June
10%
2018
July - December
70%
Total 26%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
53%
2017
July - December
10%
2018
January - June
2018
July - December
Total 13%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
30%
2018
January - June
2018
July - December
Total 7%

Minor Efforts

No minor efforts found.

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
8%
2017
July - December
2018
January - June
2018
July - December
Total 2%

Filed Statements of Lobbying Activity and Expenditures